91桃色

ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open 91桃色

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Biotechnol Biomate, Vol 14(1)

Biomaterial Based on Silk Fibroin for the treatment of Musculoskeletal Diseases

Ratna Chowdhury*
University of Calcutta, Kolkata, India
*Corresponding Author: Ratna Chowdhury, University of Calcutta, Kolkata, India, Email: ratnachowdhury530@gmail.com

Received: 01-Jan-2024 / Manuscript No. jbtbm-24-127054 / Editor assigned: 04-Jan-2024 / PreQC No. jbtbm-24-127054(PQ) / Reviewed: 25-Jan-2024 / QC No. jbtbm-24-127054 / Revised: 26-Jan-2024 / Manuscript No. jbtbm-24-127054(R) / Accepted Date: 30-Jan-2024 / Published Date: 31-Jan-2024

Abstract

Musculoskeletal diseases, encompassing a wide range of conditions affecting bones, cartilage, muscles, and connective tissues, present significant challenges in healthcare, often resulting in pain, loss of function, and reduced quality of life for patients. Regenerative medicine, particularly tissue engineering, has emerged as a promising approach for treating musculoskeletal disorders by utilizing biomaterials to promote tissue repair and regeneration. Among these biomaterials, silk fibroin has garnered considerable attention due to its unique properties and versatile applications. This abstract provides an overview of the potential of silk fibroin-based biomaterials in the treatment of musculoskeletal diseases.

Keywords

Musculoskeletal diseases; Regenerative medicine; Musculoskeletal disorders; Fibroin based biomaterials

Introduction

Silk fibroin, derived from the silkworm Bombyx mori, is a natural protein with exceptional mechanical properties, biocompatibility, and biodegradability. These properties make silk fibroin an attractive candidate for musculoskeletal tissue engineering, where the regeneration of complex tissues such as bone, cartilage, and tendon requires scaffolds that can mimic the native tissue microenvironment and support cellular growth and differentiation.

Description

In bone tissue engineering, silk fibroin-based scaffolds have been extensively studied for their ability to promote osteogenic differentiation of Mesenchymal Stem Cells (MSCs) and facilitate bone formation [1,2]. The porous structure and mechanical properties of silk fibroin scaffolds closely resemble those of native bone tissue, providing a supportive environment for cell adhesion, proliferation, and mineralization [3,4]. Furthermore, the incorporation of bioactive molecules, such as growth factors or osteoinductive agents, into silk fibroin matrices enhances their regenerative potential, leading to improved bone healing and defect repair. Similarly, in cartilage tissue engineering, silk fibroinbased hydrogels and scaffolds have shown promise in promoting chondrogenic differentiation of MSCs and supporting the formation of cartilage-like tissues [5]. The tunable mechanical properties and biocompatibility of silk fibroin allow for the development of scaffolds that mimic the viscoelasticity and biochemical composition of native cartilage, facilitating cell attachment, matrix production, and tissue integration. Additionally, the controlled release of growth factors or chondrogenic inducers from silk fibroin matrices further enhances cartilage regeneration and repair [6,7]. Silk fibroin-based biomaterials have also been investigated for tendon and ligament tissue engineering, where the hierarchical structure and mechanical properties of silk fibroin scaffolds closely resemble those of native tendon and ligament tissues [8]. Silk fibroin matrices provide a conducive environment for tenogenic differentiation of MSCs and the organization of collagen fibers, leading to the formation of functional tendon-like tissues. Moreover, the incorporation of growth factors or tenogenic inducers into silk fibroin scaffolds enhances tendon regeneration and improves mechanical strength and functionality [9,10].

Conclusion

Overall, silk fibroin-based biomaterials hold great promise for the treatment of musculoskeletal diseases, offering customizable scaffolds with tailored properties for promoting tissue regeneration and repair. Ongoing research efforts aimed at optimizing silk fibroin scaffold design, enhancing bioactivity, and elucidating their interactions with cells and tissues are essential for translating these innovations into effective clinical therapies. With continued advancements in silk fibroin-based biomaterials, regenerative medicine holds the potential to revolutionize the treatment of musculoskeletal disorders and improve patient outcomes.

References

  1. Halverson KM (2005) . J Biol Chem 280:34056–62.
  2. , ,

  3. Bayley H, Martin CR (2000) . Chem Rev 100:2575–94.
  4. , ,

  5. Graham MD (2003). . J Lab Autom 8:72–81.
  6. , Crossref,

  7. Wang C, Zou P, Yang C, Liu L, Cheng L, et al. (2019). .Sci China Life Sci62: 1459-1471.
  8. , ,

  9. Prosdocimi F, Farias ST, José MV (2022) .Theory Biosci141: 339-347.
  10. , ,

  11. Wanunu M (2012) .Phys Life Rev 125-158.
  12. , ,

  13. Hazen RM (2006). .Am Mineral 91: 1715.
  14. , Crossref,

  15. Vay LK, Mutschler H (2019) .Emerg Top Life Sci3: 469-475.
  16. , ,

  17. Deblois RW, Bean CP, Wesley RKA (1977) . J Colloid Interface Sci 61:323–35.
  18. , ,

  19. Kasianowicz JJ, Robertson JWF, Chan ER, Reiner JE, Stanford VM (2008). . Annual Reviews 1:737–66.
  20. ,

Citation: Chowdhury R (2024) Biomaterial Based on Silk Fibroin for the treatmentof Musculoskeletal Diseases y. J Biotechnol Biomater, 14: 367.

Copyright: © 2024 Chowdhury R. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top